S100P and breast carcinoma: Based on existing studies, it is found that the abnormal expression of S100P is associated with a variety of tumors, and increased S100P expression is related to poor prognosis.30,31 Cong et al32 found that in breast cancer, S100P promotes tumor progression but enhances chemosensitivity.